4th Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$680,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Supply chain & Buy American issues (COVID-19 related) Importation

LobbyistCovered position, as disclosed
SUSIE AHN —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER New Sen. Kent Conrad (ND), Special Assistant and Staff Assistant (Feb 2001- April 2005
CAROLINE QUAT NA
STEPHANIE WISWALL —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Health Issues HCR

Value of Prescription Drugs Drug Pricing Transparency S. 1895, Lower Health Care Costs Act COVID-19 Vaccine and Therapy Development COVID-19 response packages * Healthcare policy & reimbursement *FY2021 Omnibus and COVID Relief and Response Act - H.R. 133, H. Rules Comm. Print 116-68 *Discussions related to a possible increase in the Federal average manufactures price cap

LobbyistCovered position, as disclosed
SUSIE AHN —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER New Sen. Kent Conrad (ND), Special Assistant and Staff Assistant (Feb 2001- April 2005)
CAROLINE QUAT NA
STEPHANIE WISWALL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1895 (116th), H.R. 133 (116th)

Medicare/Medicaid MMM

Medicare Part D & B Coverage and Reimbursement Legislative proposals to change Medicare Part D Changes to the Medicaid Drug Rebate Program (AMP Cap) Medicaid drug pricing reporting H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs ESRD PPS, Medicare coverage ANPRM International Pricing Index Model for Medicare Part B Drugs Proposed Rule: Medicaid Program: Establishing Minimum Standards in Medicaid State Drug Utilization * Medicaid and 340B issues & drug discount program *Importation and Most Favored Nations * H.R.8845, Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020

LobbyistCovered position, as disclosed
SUSIE AHN —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER New Sen. Kent Conrad (ND), Special Assistant and Staff Assistant (Feb 2001- April 2005)
CAROLINE QUAT NA
STEPHANIE WISWALL —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 8845 (116th), H.R. 107 (116th)

Pharmacy PHA

Medicare Part D coverage and reimbursement Value of Prescription Drugs Innovative Payment Model (VBAs) Price Transparency Medicaid and 340B issues & drug discount program H.R. 1499, Protecting Consumer Access to Generic Drugs Act S. 1416, Affordable prescriptions for Patients Act H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs ANPRM: Importation of Prescription drugs and Most Favored Nations

LobbyistCovered position, as disclosed
SUSIE AHN —
HELEN DWIGHT —
THADDEUS FLOOD —
AARON W HUNTER New Sen. Kent Conrad (ND), Special Assistant and Staff Assistant (Feb 2001- April 2005
CAROLINE QUAT NA
STEPHANIE WISWALL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1416 (116th), H.R. 1499 (116th), H.R. 107 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.